Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01899040 · ClinicalTrials.gov registry record · NA
A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
A NA study, sponsored by Scion NeuroStim.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01899040: Completed NA study, sponsored by Scion NeuroStim.
NCT01899040 is a NA study that has completed, run by Scion NeuroStim. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01899040, a NA study, has completed, sponsored by Scion NeuroStim.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a randomized, blinded study designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of episodic migraine headaches.
Primary Outcome
Change in the average total number of Monthly Migraine Headache Days (number of days in the month that a participant experienced a migraine) after 3 months of treatment comparable to the pre-device use Baseline Period of 1 month, as reported in a headache diary. Negative number indicated improvement (a reduction in the average number of migraine headache days experienced per month).
Interventions
- DEVICE neuromodulation for episodic migraine headache
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT01899040 record still lists
NCT01899040 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which neuromodulation for episodic migraine headache is the first listed.
NCT01899040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01899040 about?
NCT01899040 is a clinical study titled "A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache". This is a randomized, blinded study designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of episodic migraine headaches.
What is the current status of trial NCT01899040?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2013-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01899040?
The interventions under investigation include: neuromodulation for episodic migraine headache (DEVICE).
Who is sponsoring clinical trial NCT01899040?
This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01899040's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia